应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BBH VanEck Biotech ETF
交易中 10-07 12:29:58 EDT
239.87
+3.57
+1.51%
最高
239.97
最低
234.82
成交量
3,464
今开
234.82
昨收
236.30
日振幅
2.18%
总市值
4.81亿
流通市值
4.81亿
总股本
200.65万
成交额
82.48万
换手率
0.17%
流通股本
200.65万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
吉利德科学逆势涨超2%
格隆汇 · 10-07 22:20
吉利德科学逆势涨超2%
美股深夜,半导体跳水,迈威尔科技跌超2%;中国资产下跌,阿里、百度、霸王茶姬飘绿;医药股逆市走高,礼来涨超2%,艾伯维公司股价创新高
中新经纬 · 10-07 22:19
美股深夜,半导体跳水,迈威尔科技跌超2%;中国资产下跌,阿里、百度、霸王茶姬飘绿;医药股逆市走高,礼来涨超2%,艾伯维公司股价创新高
美股生物医药股逆市上扬,安进涨超3%、礼来涨超2%
老虎资讯综合 · 10-07 22:06
美股生物医药股逆市上扬,安进涨超3%、礼来涨超2%
摩根大通将吉利德科学目标价从160美元上调至170美元。
智通财经 · 10-07 12:19
摩根大通将吉利德科学目标价从160美元上调至170美元。
摩根大通:将再生元制药公司(REGN.US)目标价从900美元上调至950美元。
智通财经 · 10-06 12:22
摩根大通:将再生元制药公司(REGN.US)目标价从900美元上调至950美元。
吉利德科学:CEO减持1.5万股,套现约221.85万美元
南方财经网 · 10-03
吉利德科学:CEO减持1.5万股,套现约221.85万美元
安进一种自身免疫药物在后期临床试验达到主要目标
格隆汇 · 09-24
安进一种自身免疫药物在后期临床试验达到主要目标
安进宣布Dazodalibep在干燥综合征III期试验中达到主要终点
投资观察 · 09-22
安进宣布Dazodalibep在干燥综合征III期试验中达到主要终点
安进股价盘前大涨逾4%,受第三期临床试验结果提振。
智通财经 · 09-22
安进股价盘前大涨逾4%,受第三期临床试验结果提振。
福泰制药宣布Inaxaplin在特定AMKD患者群体中取得积极结果,第13周UACR显著降低42.7%
投资观察 · 09-22
福泰制药宣布Inaxaplin在特定AMKD患者群体中取得积极结果,第13周UACR显著降低42.7%
安进宣布Dazodalibep治疗中重度系统性干燥综合征的3期临床试验取得积极顶线结果
美股速递 · 09-22
安进宣布Dazodalibep治疗中重度系统性干燥综合征的3期临床试验取得积极顶线结果
安进:Dazodalibep在系统性疾病活动方面展现出统计学显著且具有临床意义的改善
美股速递 · 09-22
安进:Dazodalibep在系统性疾病活动方面展现出统计学显著且具有临床意义的改善
安进:Dazodalibep治疗中重度症状性干燥综合征的Oasiz 303三期研究预计2026年第四季度完成
美股速递 · 09-22
安进:Dazodalibep治疗中重度症状性干燥综合征的Oasiz 303三期研究预计2026年第四季度完成
福泰制药:Inaxaplin在两种AMKD患者队列中均展现良好安全性与耐受性
美股速递 · 09-22
福泰制药:Inaxaplin在两种AMKD患者队列中均展现良好安全性与耐受性
福泰制药公布Inaxaplin针对APOL1介导肾病(AMKD)其他人群的2B期AMPLIFIED研究积极结果,并完成2/3期AMPLITUDE试验入组
美股速递 · 09-22
福泰制药公布Inaxaplin针对APOL1介导肾病(AMKD)其他人群的2B期AMPLIFIED研究积极结果,并完成2/3期AMPLITUDE试验入组
福泰制药:Inaxaplin显著降低UACR达42.7%——针对适度蛋白尿APKD患者展现积极疗效
美股速递 · 09-22
福泰制药:Inaxaplin显著降低UACR达42.7%——针对适度蛋白尿APKD患者展现积极疗效
福泰制药获Leerink Partners恢复覆盖,给予跑赢大盘评级及594美元目标价
美股速递 · 09-21
福泰制药获Leerink Partners恢复覆盖,给予跑赢大盘评级及594美元目标价
吉利德科学扩大六项免许可费自愿授权协议,力推每年一次HIV预防药Lenacapavir
美股速递 · 09-16
吉利德科学扩大六项免许可费自愿授权协议,力推每年一次HIV预防药Lenacapavir
百时美施贵宝就安进拟推出的Opdivo生物类似药提起诉讼
格隆汇 · 09-16
百时美施贵宝就安进拟推出的Opdivo生物类似药提起诉讼
吉利德科学携手巴西卫生部,共促Lenacapavir本地化生产新篇章
美股速递 · 09-15
吉利德科学携手巴西卫生部,共促Lenacapavir本地化生产新篇章
公司概况
公司名称:
VanEck Biotech ETF
所属市场:
NASDAQ
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":239.8708,"timestamp":1791390459945,"preClose":236.2992,"halted":0,"volume":3464,"delay":0,"changeRate":0.015114735894154484,"floatShares":2006503,"shares":2006503,"eps":0,"marketStatus":"交易中","change":3.5716,"latestTime":"10-07 12:29:58 EDT","open":234.82,"high":239.97,"low":234.82,"amount":824847.61072,"amplitude":0.021794,"askPrice":239.58,"askSize":200,"bidPrice":239.29,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1791403200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":236.2992,"sharesOutstanding":1976503,"nav":240.53359,"aum":482631368.2,"dividendRate":0.00394,"bidAskSpread":0.001134,"preHourTrading":{"tag":"盘前","latestPrice":236.2992,"preClose":236.2992,"latestTime":"08:18 EDT","volume":1,"amount":236.2992,"timestamp":1791375480029,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":235.54,"preClose":236.2992,"latestTime":"19:30 EDT","volume":18,"amount":4251.836,"timestamp":1791329402755,"change":-0.7592,"changeRate":-0.003213,"amplitude":0},"volumeRatio":0.64795,"impliedVol":0.2154,"impliedVolPercentile":0.757},"requestUrl":"/m/hq/s/BBH/wiki","defaultTab":"wiki","newsList":[{"id":"2673016696","title":"吉利德科学逆势涨超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673016696","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673016696?lang=zh_cn&edition=full","pubTime":"2026-10-07 22:20","pubTimestamp":1791382856,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4550","LU1934455194.USD","IE00B19Z3581.USD","LU1571399168.USD","LU0859254822.USD","IE00BKVL7J92.USD","TMED","BK4566","BBH","BK4139","LU0320765992.SGD","LU2468319806.SGD","BK4583","IE00B19Z3B42.SGD","LU0965508806.USD","LU1057294990.SGD","LU0882574055.USD","LU0234570918.USD","LU1037948541.HKD","LU1066051498.USD","LU2089984988.USD","BIB","BMED","LU1934455863.HKD","LU0122379950.USD","BK4568","LU1839511570.USD","IBB","LU1934455277.USD","TBXU","IBBQ","IE0002270589.USD","LU0823416689.USD","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","LU1778281490.HKD","GILD","BK4588","LU1430594728.SGD","LU0289739699.SGD","LU2357627491.SGD","MEDI","LU0109394709.USD","IE00BZ1G4Q59.USD","SG9999015952.SGD","LU1037948897.HKD","LU0965509010.AUD","SG9999015978.USD","LU1023059063.AUD","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673601697","title":"美股深夜,半导体跳水,迈威尔科技跌超2%;中国资产下跌,阿里、百度、霸王茶姬飘绿;医药股逆市走高,礼来涨超2%,艾伯维公司股价创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2673601697","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673601697?lang=zh_cn&edition=full","pubTime":"2026-10-07 22:19","pubTimestamp":1791382754,"startTime":"0","endTime":"0","summary":"北京时间7日晚,美股费城半导体指数跌2%。截至发稿,成分股中,Coherent跌超5%,安森美半导体、迈威尔科技、应用材料等跌超2%。中国资产下跌,纳斯达克中国金龙指数盘初跌约1%。虎虎科技跌超11%,万国数据、有道、新氧跌超3%,霸王茶姬、陆金所控股、阿里巴巴、百度、金山云等飘绿。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610073888963964.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610073888963964.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["RDVI","LU1046421795.USD","LLII","MRVU","LU0114720955.EUR","LU2746668461.USD","LU0238689110.USD","LU1093756168.USD","LU0174119429.USD","LU0882574055.USD","LU1823568750.SGD","LU2433249047.HKD","BK4554","LU2237443465.HKD","LU0994945656.USD","LU1935042991.SGD","SG9999002232.USD","BK4565","LU0868494617.USD","LU0061474960.USD","BK4578","LU1720051017.SGD","LU1506573853.SGD","LU1894683348.USD","IE0004086264.USD","LU0158827781.USD","LU1037948541.HKD","AIFD","LU1115378108.SGD","LU0057025933.USD","LU2272731782.SGD","LU2746668974.SGD","MRVL","LU0310800379.SGD","COHC","LU1023059063.AUD","LU2473716301.USD","COHQ","LU0175139822.USD","IE00BSNM7G36.USD","LU1066051225.USD","LU0079474960.USD","SGXZ81514606.USD","LU2413666699.HKD","LU1032955483.USD","LU0348816934.USD","BK4518","BK4602","LU0708994859.HKD","AMAU","ONX","SG9999015986.USD","LU0347712357.USD","BABU","LU0320765646.SGD","BMED","SG9999001424.SGD","FAI","SG9999014898.SGD","IE00B1XK9C88.USD","SOX","LU1430594728.SGD","BK4588","LU0797268264.HKD","LU0456842615.SGD","LU1769817096.USD","SG9999011175.SGD","LU0889566641.SGD","IE00B4JS1V06.HKD","IE00B7SZL793.SGD","LU0553294199.USD","WDNA","LU2148611432.USD","LU0094547139.USD","LU0726765562.USD","AIS","04336","LU2552382058.USD","LU2430703178.SGD","BK4526","IE00BKPKM429.USD","BK4599","LU2133065610.SGD","LU2125909247.SGD","SG9999001440.SGD","LU1688375341.USD","LU1051769294.HKD","SPRX","LU0234572021.USD","SG9999013999.USD","DRGN","LU0545039389.USD","LU1989772923.USD","LU2236285917.USD","LU0792757196.USD","BK4502","IE00B42XCP33.USD","LU1978683503.SGD","LU0289739699.SGD","LU2125909593.SGD","SGXZ31699556.SGD","LU1093756325.SGD","LU2360106947.USD","LU0786609619.USD","LU2129689431.USD","LU1623119135.USD","LU0124676726.USD","LU1291159041.SGD","LU2430703095.HKD","LU2347655156.SGD","LU1162221912.USD","BK4550","LU1003077747.HKD","CANC","SG9999000418.SGD","LU0348766576.USD","LU0820561909.HKD","FHLC","IE00BVYPNW00.USD","IE00BF5LJ272.USD","IE0005OL40V9.USD","LU1571399168.USD","LU2403377893.USD","LU1152091168.USD","IE00B19Z3B42.SGD","LU1548497426.USD","LU1051768304.USD","IYH","SG9999002224.SGD","LU1064131342.USD","BK4512","LU2505996681.GBP","GDOC","LU0289961442.SGD","IE00BDGV0183.EUR","LU0225283273.USD","LU0708995401.HKD","LU1989773731.SGD","LU1066051811.HKD","LU1515016050.SGD","LU2087625088.SGD","LU0889565833.HKD","04332","IE0004445015.USD","IE00BZ199S13.USD","LU1674673428.USD","ALBmain","SMHX","LU1303367103.USD","LUMA","LU0081259029.USD","LU1169589451.USD","LU0426417589.USD","LU1712237335.SGD","LU2360107325.USD","LU0158827948.USD","MEDI","TINY","SHOC","LU2063271972.USD","LU0823434583.USD","LU1043141396.HKD","PSI","IE00BMPRXQ63.HKD","LU0323591593.USD","LU0354030438.USD","LU1868837300.USD","MEDX","BK4592","LU1059921491.USD","IE00BQXX3D17.EUR","LU1267930813.SGD","LU2168564495.EUR","LU2237443895.HKD","IE00BJJMRZ35.SGD","LU0328353924.USD","LU2896262040.SGD","LU0251143458.SGD","LU0466842654.USD","LU0965509101.SGD","BK4604","LU2552382132.HKD","IE00BMPRXR70.SGD","LU1235294995.USD","LU1914381329.SGD","EGGY","LU1032466523.USD","LU2129689514.USD","FOTO","LU1778281490.HKD","LU2361044865.SGD","BK4583","SG9999014914.USD","LU2458330243.SGD","LU2237443622.USD","IE0000B7K699.USD","LU2242646821.SGD","IE0009356076.USD","LU1366192091.USD","LU1769817179.HKD","LU2237443382.USD","LU0011850046.USD","LU2471134796.USD","LU2023251221.USD","LU1642822529.SGD","PPH","LU1989764748.USD","LU2592432038.USD","LU0889565916.HKD","LU0109391861.USD","IE00B2B36J28.USD","LU2552382215.SGD","ELIL","IE00B3PB1722.GBP","LU0880133367.SGD","LU2458330169.SGD","LU0942090050.USD","IE00B775H168.HKD","BK4543","IE0009355771.USD","LU0053666078.USD","LU0061475181.USD","LU1861219969.SGD","MRVX","THNR","IE00BQXX3C00.GBP","LU1046422090.SGD","LU2112291526.USD","LU2602419157.SGD","IE00BWXC8680.SGD","LU0133085943.USD","LU0456855351.SGD","IE00BKDWB100.SGD","BK4585","LU2471134879.HKD","LU2461242641.AUD","LU1923622614.USD","LU0912757837.SGD","SG9999001176.USD","LU0472753341.HKD","LU0965509283.SGD","LU1267930573.SGD","LU0276348264.USD","LU2456880835.USD","IE00B4R5TH58.HKD","LU2750360641.GBP","LU0109394709.USD","LU0689472784.USD","IE00B19Z3581.USD","ARTY","LU1861214812.USD","COHX","IE00BFXG1179.USD","LU1674673691.USD","LU0353189763.USD","IE00BN29S564.USD","LU0965509010.AUD","LU1854103824.USD","LU0052756011.USD","EPAI","IE00BVYPNV92.GBP","LU0047713382.USD","LU2129689605.HKD","LU0642271901.SGD","IE00B7KXQ091.USD","DTCR","LU0097036916.USD","FTXH","IHE","LU2168564222.USD","BK4587","LU2272731600.USD","BK4007","ILDR","GILD","QQQG","SG9999015945.SGD","LU0943347566.SGD","LU0289960550.SGD","BK4567","BK4575","LU0058720904.USD","LU0170899867.USD","LU2247934214.USD","LU1934455194.USD","LU0640476718.USD","LU0061474705.USD","LU0106261372.USD","PJP","IE00BFMHRM44.USD","LU2237443549.SGD","GLAM","LU2462157665.USD","IE0034235303.USD","BK4532","LU0109392836.USD","BK4614","TMED","LU2357627491.SGD","LU0316494557.USD","BK4505","LU0979878070.USD","PBE","IE00BFSS7M15.SGD","LU2089985449.USD","LU0274383776.USD","LU0348814723.USD","LU2756315664.SGD","IE000MB6IJN5.SGD","LU2347655073.USD","LU1035775433.USD","LU2089283258.USD","LU0385154629.USD","LU0203202063.USD","LU1852331112.SGD","BK4139","LU0098860793.USD","LU1551013425.SGD","LU0426412945.USD","LU1983260115.SGD","RXL","LU0417517546.SGD","LU1988902786.USD","IE00BBT3K403.USD","LU1242518931.SGD","LU0348767384.USD","BK4607","BK4610","JDOC","VHT","LU0162691827.USD","LU0203201768.USD","LU1814569148.SGD","BK4534","LU1221951046.USD","SG9999018857.SGD","LU2242652126.USD","AMA","BK4531","XNTK","BK4504","LU2413666426.HKD","BK4524","IE00BJT1NW94.SGD","LU0821914370.USD","LU1084165304.USD","BK4535","BK4563","LU1670628061.USD","LU2361044949.HKD","LU0345770993.USD","LU1267930490.SGD","IBB","LU1496350502.SGD","BK4566","LU2111349929.HKD","BK4519","GTEK","LU2505996509.AUD","WUGI","SGXZ57979304.SGD","LU1261432733.SGD","FTXL","LU1974910355.USD","LU1037948897.HKD","LU2023250843.SGD","IE00BMPRXN33.USD","TRUH","LU2290526834.HKD","LU0056508442.USD","BK4612","IE00BLSP4452.SGD","LU0154236417.USD","BK4581","APMI","ABBV","LU2098885051.SGD","BK4574","LU0395794307.EUR","LU1244550494.USD","HRTS","BK4558","LU0210528500.USD","LU2226246903.HKD","BIDU","LU0124384867.USD","LU1236620834.HKD","COHR","LU1316542783.SGD","LU1267930730.SGD","LU0345769128.USD","LU0359201612.USD","LU1323610961.USD","LU0444973449.USD","XLV","IE00BK4W5M84.HKD","LU0266013472.USD","BK4157","LU1066051498.USD","RDVY","CLIX","BBH","LU0354030511.USD","LU2931357623.SGD","GB00BDT5M118.USD","LU2471134523.USD","LU0256863902.USD","LU2089984988.USD","LU2108987350.USD","LU0683600562.USD","LU1861215975.USD","BABX","BBYY","IE00B0JY6N72.USD","IBBQ","BK4141","LU0096362180.USD","LU1061106388.HKD","LU0965508806.USD","LU0320765992.SGD","LU2023250504.SGD","LU0949170772.SGD","SMH","BK4579","DRAG","LU0868494708.USD","BK4552","IE00BGHQF631.EUR","LU1815336760.USD","LU1854104046.USD","LU0823416689.USD","BABW","BK4559","LU1074936037.SGD","SG9999014880.SGD","LU2468319806.SGD","SG9999003800.SGD","KBDU","LU1992135399.USD","IE00BQXX3F31.USD","LU0957808578.USD","IE00BZ1G4Q59.USD","LU1069344957.HKD","LU1023057109.AUD","IE00BJJMRY28.SGD","LU1585245621.USD","LU2028103732.USD","IE00B5949003.HKD","SG9999014906.USD","TDV","LU0957791311.USD","LU2237438978.USD","LU0348723411.USD","IE000SO60NU8.SGD","ON","LU1242518857.USD","LU1105468828.SGD","TBXU","LU0444971666.USD","LU0689626769.HKD","LU1282648689.USD","IE0004445239.USD","LLY","LU0651947912.USD","LU0918141705.HKD","LU2756315318.SGD","LU0795875086.SGD","MVLL","BK4077","BABC","CHA","IE00B66KJ199.SGD","LU1043141123.HKD","IE000F7OJYX1.SGD","LU1551013342.USD","LU1989763005.USD","LU0724618433.USD","LU1815333072.USD","IE000BZT7R73.USD","LU0738911758.USD","ONLN","LU0211328371.USD","IE00BN8TJ469.HKD","LU2430703251.USD","LU0359202008.SGD","LU1057294990.SGD","LU0203347892.USD","LU1153585028.USD","LU1803068979.SGD","IE0031619046.USD","LU0122379950.USD","LU1221951129.SGD","SG9999015952.SGD","LU1169590202.USD","LU0198837287.USD","LU0661504455.SGD","LU1868837136.USD","SG9999015978.USD","LU1152091754.HKD","SOXQ","LU1127390331.HKD","LU0234570918.USD","LU2322448957.HKD","IE000WAW04H5.SGD","IE00B1BXHZ80.USD","LU2361045086.USD","LU0511384066.AUD","LU0918141887.USD","LU0310799852.SGD","LU1145028129.USD","LU1989771016.USD","LU1267930227.SGD","BIB","LU2471134952.CNY","LU0072461881.USD","LU0289739343.SGD","IE0001KFT4U8.USD","AMAT","BK4220","LU0640798160.USD","SG9999018865.SGD","AGNG","IE0002141913.USD","IE00BFSS8Q28.SGD","LU2357305700.SGD","LU1868836914.USD","LU1979441026.SGD","LU0029864427.USD","LU0072462343.USD","LU0787776722.HKD","LU2750360997.AUD","LU1196500208.SGD","09888","LU0985320562.USD","FDTX","LU0070217475.USD","LU2211815571.USD","LU1228905540.USD","LU1629891620.HKD","LU1868836757.USD","LU0795875169.SGD","LU0287142896.SGD","LU1244550221.USD","LU0096364046.USD","LU1066053197.SGD","LU0882574139.USD","LU1119994496.HKD","LU2543165471.USD","LU2491050071.SGD","IE00B19Z4B17.USD","LU2491049909.HKD","LU2023250330.USD","MHIP","GDS","KBAB","BK4516","SOXY","LU0353189680.USD","LU1228905037.USD","IE00BJLML261.HKD","LU2462591350.SGD","LU1804176565.USD","BABA","LU0210536198.USD","CHPS","BK4514","BK4538","FXL","LU0545562505.USD","LU0345769631.USD","LU0859254822.USD","LU0820561818.USD","LU2298322129.HKD","LU1048588211.SGD","LU0672654240.SGD","LU0320765059.SGD","LU1496350171.SGD","LU0823421416.USD","SG9999017495.SGD","LU0173614495.USD","LU1992135472.HKD","09698","COHH","LU2168564149.EUR","QQQA","LU2089284900.SGD","IE00BKVL7J92.USD","LU0106959298.USD","LU2324357040.USD","LU1934455277.USD","OZEM","BK4605","LU1868836591.USD","LU0128525689.USD","LU1244550577.SGD","LU1989772840.SGD","IE00B3T34201.USD","LU1861220033.SGD","LU0310800965.SGD","LU1732800096.USD","LU0823434740.USD","LU2087621335.USD","LU1280957306.USD","CURE","LU2491050154.USD","JNJ","BIDG","LU1008478684.HKD","LU2322448791.USD","LU2168563687.JPY","LU2487616109.SGD","LU2264538146.SGD","LU0471298694.HKD","AMGN","IE00BJJMRX11.SGD","IXJ","LU1236620750.USD","LU2168564065.EUR","LU0187121727.USD","LU1121112475.USD","BK4503","LU2360107168.USD","LU0203345920.USD","SGXZ51526630.SGD","LU0072913022.USD","LU1934455863.HKD","IE00BD6J9T35.USD","ELIS","LU1232071149.USD","BK4539","BK4515","LLYZ","LU2106854487.HKD","ONG","LU1720051108.HKD","SG9999001176.SGD","LU2265009873.SGD","LU0820562030.AUD","LU1048596156.SGD","BK4209","LU0861579265.USD","SGXZ80539844.SGD","IE000M9KFDE8.USD","LU0006306889.USD","BABO","LU0067412154.USD","LU1718418525.SGD","BK4533","LU0651946864.USD","LU1894683264.USD","LU0964807845.USD","BK4122","LU0211327993.USD","LU1721428933.USD","IE00B7SZLL34.SGD","LU1839511570.USD","LU2211814178.USD","09988","LU0471298777.SGD","BK4527","BK4548","LU1732799900.SGD","LU1983299246.USD","IE0004091025.USD","BK4147","LU0476273544.USD","IE00BLSP4239.USD","LU0501845795.SGD","LU2271345857.HKD","IE00BFTCPJ56.SGD","LU1670627923.USD","LU0127658192.USD","LU0823421333.USD","BK4116","IE0002270589.USD","LU0256863811.USD","LU0128525929.USD","LU0345770308.USD","LLYX","LU2244417387.USD","LU2237443978.SGD","LU2272731865.HKD","SGXZ99366536.SGD","BK4148","LU1929549753.HKD","BK4529","LU1917777945.USD","BK4568","LU0432979614.USD","LU1691799644.USD","LU1989764664.SGD","LU0069063385.USD","IE00BK4W5L77.USD","LU2417539215.USD","LU2213496289.HKD","LU1880383366.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152649064","title":"美股生物医药股逆市上扬,安进涨超3%、礼来涨超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152649064","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152649064?lang=zh_cn&edition=full","pubTime":"2026-10-07 22:06","pubTimestamp":1791382000,"startTime":"0","endTime":"0","summary":"10月7日,美股生物医药股逆市上扬,$安进(AMGN)$涨超3%,$吉利德科学(GILD)$涨近3%,$礼来(LLY)$、$强生(JNJ)$、$艾伯维公司(ABBV)$涨超2%。","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1196500208.SGD","IYH","LU0238689110.USD","LU0889565916.HKD","LU1989771016.USD","LU0128525929.USD","LU2896262040.SGD","LU0162691827.USD","SGXZ81514606.USD","LU0385154629.USD","MEDI","LU0211327993.USD","LU0353189680.USD","LU0965508806.USD","TRUH","AGNG","IE00BLSP4452.SGD","LU0006306889.USD","LU0106261372.USD","IE000WAW04H5.SGD","LU1868837136.USD","LU1496350171.SGD","BK4139","BK4578","LU2552382132.HKD","SG9999013999.USD","IE00BVYPNW00.USD","LU0203202063.USD","LU0094547139.USD","IE000F7OJYX1.SGD","LU0726765562.USD","LU1244550221.USD","LU0354030511.USD","LU2089283258.USD","LU2491049909.HKD","LU0466842654.USD","LU2468319806.SGD","LU0345769128.USD","LU2360106947.USD","LU0289739699.SGD","IE00BWXC8680.SGD","IE00BJJMRY28.SGD","LU2108987350.USD","LU2129689431.USD","SG9999014880.SGD","LU0545039389.USD","LU1670627923.USD","IE00BZ1G4Q59.USD","IE00BLSP4239.USD","LU1732799900.SGD","LU1145028129.USD","LLY","IE00BJT1NW94.SGD","LU0553294199.USD","LU2023250330.USD","BK4592","LU1043141123.HKD","SG9999015952.SGD","LU2111349929.HKD","LU0225283273.USD","LU0320765992.SGD","IE000SO60NU8.SGD","LU0672654240.SGD","LU0426412945.USD","LU1066051498.USD","LU0471298777.SGD","LU1934455194.USD","IE00BJLML261.HKD","GB00BDT5M118.USD","LU1032466523.USD","LU2433249047.HKD","LU1585245621.USD","LU1261432733.SGD","SG9999011175.SGD","LU2357305700.SGD","LLII","IE00BGHQF631.EUR","LU0786609619.USD","IE00BK4W5M84.HKD","IE00B2B36J28.USD","LU1917777945.USD","LU1127390331.HKD","LU1221951129.SGD","LU1674673691.USD","LU2168564495.EUR","LU2592432038.USD","LU1935042991.SGD","GDOC","LU0823434583.USD","LU2168563687.JPY","LU0861579265.USD","LU2471134523.USD","IE00BVYPNV92.GBP","LU0689472784.USD","LU2552382058.USD","LU1868836591.USD","IE00B4JS1V06.HKD","LU2750360997.AUD","BK4534","BK4581","LU0097036916.USD","LU1670628061.USD","LU0471298694.HKD","IE00BN8TJ469.HKD","LU1571399168.USD","LU2756315318.SGD","161726","GILD","LU2125909247.SGD","IE0004445239.USD","JNJ","BK4516","SG9999018865.SGD","IE000M9KFDE8.USD","LU1804176565.USD","OZEM","LU2237443465.HKD","LU2237443382.USD","LU2237443978.SGD","ELIL","RXL","LU0965509283.SGD","LU2430703251.USD","LU1236620834.HKD","IBBQ","IE00BKPKM429.USD","LU1989772840.SGD","LU0738911758.USD","LU0109394709.USD","LU2456880835.USD","BK4559","LU1323610961.USD","LU0964807845.USD","LU0198837287.USD","LU2265009873.SGD","LU0122379950.USD","LU1974910355.USD","LU1057294990.SGD","SGXZ57979304.SGD","LU0211328371.USD","ELIS","LU1548497426.USD","LU1066051811.HKD","LU2264538146.SGD","LU1162221912.USD","IE0001KFT4U8.USD","LU2211815571.USD","CURE","LU0689626769.HKD","LU0859254822.USD","LU0174119429.USD","IE00B19Z3B42.SGD","SG9999014906.USD","LU0320765059.SGD","LU2129689605.HKD","BMED","LU1244550577.SGD","LU0234572021.USD","SG9999002232.USD","LU2471134952.CNY","LU1066051225.USD","LU1236620750.USD","LU1914381329.SGD","XBI","LU0912757837.SGD","LU1267930573.SGD","LU1506573853.SGD","LU2112291526.USD","ILDR","IE00BFSS8Q28.SGD","LU1032955483.USD","LU1988902786.USD","LU2471134879.HKD","LU0472753341.HKD","LU0158827781.USD","XLV","LU2361045086.USD","LU0320765646.SGD","LU1280957306.USD","LU1989772923.USD","PJP","LU0310799852.SGD","LU0820562030.AUD","LU1868836914.USD","IE0009355771.USD","TBXU","LU1074936037.SGD","LU0882574055.USD","LU1732800096.USD","LU0256863811.USD","LU0079474960.USD","BK4550","LU1718418525.SGD","JDOC","LU0882574139.USD","LU1430594728.SGD","LU0353189763.USD","LU1093756325.SGD","IE00BJJMRZ35.SGD","IE0004445015.USD","LU0114720955.EUR","LU2750360641.GBP","LU0203347892.USD","LU2125909593.SGD","LU1691799644.USD","LU2430703095.HKD","BK4533","LU1066053197.SGD","SG9999014898.SGD","LU2491050154.USD","LU0323591593.USD","LU2430703178.SGD","SG9999003800.SGD","LU2756315664.SGD","HRTS","FHLC","LU0417517546.SGD","LU1720051108.HKD","LU1228905540.USD","LU2417539215.USD","LU1629891620.HKD","LU2361044949.HKD","MEDX","IXJ","LU0057025933.USD","LU0310800379.SGD","LU1366192091.USD","LU0069063385.USD","LU1267930813.SGD","SG9999017495.SGD","BK4583","IE00B7SZLL34.SGD","LU2063271972.USD","LU1674673428.USD","LU0545562505.USD","LU1059921491.USD","LU2746668974.SGD","LU0994945656.USD","BK4007","LU1934455277.USD","LU0289961442.SGD","LU2357627491.SGD","IE00BFSS7M15.SGD","IHE","LU0708994859.HKD","LU2471134796.USD","SG9999001176.SGD","AMGN","LU0820561909.HKD","LU0053666078.USD","LU2746668461.USD","LU1069344957.HKD","LU2347655156.SGD","LU0109391861.USD","LU2491050071.SGD","LU1043141396.HKD","THNR","LU1983299246.USD","IE0000B7K699.USD","LU0210536198.USD","LU2462591350.SGD","IE00B19Z3581.USD","LU0210528500.USD","LU1496350502.SGD","LU1894683264.USD","LU1979441026.SGD","LU0124676726.USD","LU1814569148.SGD","LU2237443622.USD","IE000MB6IJN5.SGD","LU0868494617.USD","SG9999001440.SGD","IE0005OL40V9.USD","LU1037948897.HKD","IE00B3PB1722.GBP","LU0098860793.USD","IE00BKDWB100.SGD","LU1267930730.SGD","IE00B42XCP33.USD","LU0456855351.SGD","BIB","LU2023251221.USD","BBH","IE0034235303.USD","LU0795875086.SGD","IE0002141913.USD","SG9999015945.SGD","LU2087621335.USD","SGXZ99366536.SGD","LU1720051017.SGD","SGXZ51526630.SGD","LU0289739343.SGD","LU0395794307.EUR","LU1064131342.USD","LU1121112475.USD","SGXZ80539844.SGD","BK4588","LU2461242641.AUD","GLAM","CANC","IE000BZT7R73.USD","LU1244550494.USD","LU2242646821.SGD","IE00BKVL7J92.USD","LU0203345920.USD","LU1934455863.HKD","SG9999015986.USD","VHT","LU0170899867.USD","LU2168564065.EUR","LU2236285917.USD","BK4566","LU1061106388.HKD","LU0203201768.USD","LU1839511570.USD","LU0965509010.AUD","LU0792757196.USD","LU0943347566.SGD","LU1003077747.HKD","LU1868836757.USD","LU2242652126.USD","SG9999015978.USD","LU2168564149.EUR","LU2403377893.USD","LU1221951046.USD","IE00B4R5TH58.HKD","IE00BJJMRX11.SGD","LU0058720904.USD","LU2552382215.SGD","IE00BK4W5L77.USD","BK4599","LU2237443549.SGD","IBB","BK4504","SG9999018857.SGD","LU2505996509.AUD","LU0820561818.USD","LU0266013472.USD","LU0787776722.HKD","IE00B775H168.HKD","LU0345770308.USD","LU0708995401.HKD","LU1035775433.USD","LU1291159041.SGD","LU2271345857.HKD","LU2028103732.USD","LU0072461881.USD","BK4568","SG9999014914.USD","LU0345770993.USD","LU2106854487.HKD","WDNA","LU0070217475.USD","LU2168564222.USD","LLYZ","LU1894683348.USD","SG9999001176.USD","LU2487616109.SGD","LU0868494708.USD","LU2324357040.USD","LU0256863902.USD","LU1778281490.HKD","LU1623119135.USD","LU0661504455.SGD","LU0949170772.SGD","LU2505996681.GBP","SG9999002224.SGD","LU0823416689.USD","LU1923622614.USD","IE00BSNM7G36.USD","LU1093756168.USD","LU2237443895.HKD","IE00B1BXHZ80.USD","IE00BFXG1179.USD","LU1232071149.USD","SGXZ31699556.SGD","IE00BDGV0183.EUR","LU1023059063.AUD","LU2089284900.SGD","LU1551013425.SGD","LU0133085943.USD","LU0823434740.USD","LU0965509101.SGD","LU0096364046.USD","LLYX","LU1712237335.SGD","LU2602419157.SGD","FTXH","LU2347655073.USD","BK4585","IE00B7KXQ091.USD","LU0683600562.USD","LU1929549753.HKD","LU2361044865.SGD","LU0426417589.USD","IE00B3T34201.USD","LU0158827948.USD","LU0354030438.USD","LU2213496289.HKD","LU2133065610.SGD","PPH","MHIP","LU0029864427.USD","LU0345769631.USD","LU2462157665.USD","IE00B1XK9C88.USD","LU2129689514.USD","LU2237438978.USD","LU1868837300.USD","TMED","LU1551013342.USD","LU0061475181.USD","LU0985320562.USD","LU1267930490.SGD","LU2023250504.SGD","IE00BN29S564.USD","IE00BFTCPJ56.SGD","LU0316494557.USD","BK4532","LU1228905037.USD","IE00BBT3K403.USD","LU1037948541.HKD","LU2087625088.SGD","ABBV","LU0795875169.SGD","LU0234570918.USD","LU0640476718.USD","LU0511384066.AUD","LU2089984988.USD","LU0889566641.SGD","IE0002270589.USD","PBE","LU0432979614.USD","LU0942090050.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673406721","title":"摩根大通将吉利德科学目标价从160美元上调至170美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2673406721","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673406721?lang=zh_cn&edition=full","pubTime":"2026-10-07 12:19","pubTimestamp":1791346792,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SG9999015945.SGD","LU0114720955.EUR","LU1934455194.USD","IE00B19Z3581.USD","LU2112291526.USD","LU1571399168.USD","LU0859254822.USD","UDN","IE00BKVL7J92.USD","TMED","BK4566","BBH","BK4139","LU0320765992.SGD","LU1674673428.USD","LU0965509283.SGD","LU0058720904.USD","LU0965508806.USD","LU1061106388.HKD","LU0882574055.USD","LU1037948541.HKD","LU0861579265.USD","LU2089984988.USD","BIB","PGF","BMED","SG9999015986.USD","UUP","LU1934455863.HKD","LU0122379950.USD","BK4568","TBXU","IBB","LU1934455277.USD","IBBQ","IE0002270589.USD","LU0823416689.USD","IE00BSNM7G36.USD","GILD","IE00B3T34201.USD","BK4588","LU2087621335.USD","LU0289739699.SGD","LU2357627491.SGD","MEDI","LU0109394709.USD","IE00BZ1G4Q59.USD","LU1585245621.USD","LU1037948897.HKD","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673036880","title":"摩根大通:将再生元制药公司(REGN.US)目标价从900美元上调至950美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2673036880","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673036880?lang=zh_cn&edition=full","pubTime":"2026-10-06 12:22","pubTimestamp":1791260532,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["REGN","BK4582","LU0114720955.EUR","LU0823434740.USD","LU2362540622.SGD","LU0889565916.HKD","UDN","LU2362541273.HKD","BBH","BK4139","LU0320765992.SGD","LU0053666078.USD","LU0058720904.USD","LU0882574055.USD","LU1974910355.USD","LU2089984988.USD","LU2106854487.HKD","PGF","UUP","LU2324357040.USD","TBXU","IBB","LU2362541513.USD","IBBQ","LU0823416689.USD","BK4588","LU1917777945.USD","BK4585","LU2023250504.SGD","LU0289739699.SGD","LU0109394709.USD","LU0823434583.USD","LU2237438978.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672928744","title":"吉利德科学:CEO减持1.5万股,套现约221.85万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2672928744","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672928744?lang=zh_cn&edition=full","pubTime":"2026-10-03 07:15","pubTimestamp":1790982928,"startTime":"0","endTime":"0","summary":"南财智讯10月3日电,吉利德科学(GileadSciences,Inc.,纳斯达克:GILD)董事长兼首席执行官DanielPatrickO'Day提交Form4持股变动声明。10月1日,董事长兼首席执行官DanielPatrickO'Day通过2笔交易合计减持15000股普通股,成交价格区间147.72至148.63美元,加权均价约147.90美元,套现约221.85万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610033888451721.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610033888451721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1934455863.HKD","LU2089984988.USD","LU0114720955.EUR","LU1839511570.USD","LU0882574055.USD","LU1037948541.HKD","IE00B19Z3581.USD","LU0320765992.SGD","LU1674673428.USD","BIB","IE00B7SZLL34.SGD","LU1585245621.USD","IBB","LU2324357040.USD","BK4588","LU0058720904.USD","LU0289739699.SGD","LU1571399168.USD","LU1066053197.SGD","GILD","BK4566","IE0002270589.USD","LU2357627491.SGD","BBH","BK4550","BK4578","LU1430594728.SGD","LU0823416689.USD","MEDI","BK4585","SG9999015986.USD","LU1037948897.HKD","BK4583","LU1778281490.HKD","SG9999015945.SGD","LU0889565916.HKD","IE00BSNM7G36.USD","SG9999015978.USD","TBXU","IE00B3T34201.USD","LU1934455277.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1066051498.USD","IBBQ","TMED","LU2087621335.USD","BMED","IE00B19Z3B42.SGD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669453169","title":"安进一种自身免疫药物在后期临床试验达到主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2669453169","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669453169?lang=zh_cn&edition=full","pubTime":"2026-09-24 10:32","pubTimestamp":1790217159,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0109394709.USD","BK4534","BBH","IBBQ","IE00B2B36J28.USD","LU2242646821.SGD","LU0122379950.USD","PBE","BK4139","IE00BJJMRZ35.SGD","LU2112291526.USD","IBB","BK4588","LU1061106388.HKD","SG9999001440.SGD","TBXU","IE0002141913.USD","LU0320765992.SGD","BK4585","LU0889565916.HKD","LU0058720904.USD","LU2242652126.USD","BK4581","PJP","MDTX","IE0009355771.USD","BK4599","BIB","LU1571399168.USD","BMED","LU1983299246.USD","LU0868494617.USD","PSYK","IBBJ","LU1023059063.AUD","LU2089984988.USD","LU0289739699.SGD","LU2468319806.SGD","LU1057294990.SGD","BK4566","IE00B4R5TH58.HKD","AMGN","BK4533","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121969920","title":"安进宣布Dazodalibep在干燥综合征III期试验中达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1121969920","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121969920?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:50","pubTimestamp":1790085037,"startTime":"0","endTime":"0","summary":"路透社9月22日消息——安进公司(Amgen Inc)于近日披露其关键临床进展:\n安进旗下药物Dazodalibep在针对中重度症状性干燥综合征的III期OASIZ 303研究中,成功达到主要终点,该项试验预计将于2026年第四季度完成。\n安进表示,Dazodalibep在III期干燥综合征试验中取得主要终点的积极结果,该药物在系统性疾活动度方面展现出具有统计学显著性及临床意义的改善。\n值得注意的是,这一进展为干燥综合征患者群体带来了新的治疗希望。安进公司股票代码为AMGN.O。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","LU2089984988.USD","LU2242646821.SGD","IE00B2B36J28.USD","LU0122379950.USD","BK4139","IE00B4R5TH58.HKD","LU0320765992.SGD","BIB","LU2468319806.SGD","BK4534","IBB","BK4588","LU0058720904.USD","IE0002141913.USD","LU0289739699.SGD","LU1023059063.AUD","LU1061106388.HKD","LU1571399168.USD","BK4566","IE00BFTCPJ56.SGD","LU1057294990.SGD","BBH","PJP","IE00BJJMRZ35.SGD","BK4581","LU2112291526.USD","IE0009355771.USD","BK4585","LU0109394709.USD","AMGN","LU0889565916.HKD","BK4533","TBXU","BK4599","SG9999001440.SGD","LU1983299246.USD","LU2242652126.USD","IBBQ","LU0868494617.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669114208","title":"安进股价盘前大涨逾4%,受第三期临床试验结果提振。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669114208","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669114208?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:07","pubTimestamp":1790082475,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0109394709.USD","MRNY","BME","PBPH","LFSC","BBH","IBBQ","HELX","IYH","LU0122379950.USD","LU2242646821.SGD","IBRN","PBE","PSCH","SBIO","BBP","XPH","SYNB","IBB","RXL","TBXU","LU2473716301.USD","LU0320765992.SGD","MEDI","BK4585","FTXH","LU0058720904.USD","GNOM","FBT","IE00B5TLWC47.USD","XBIX","PJP","BK4599","BIB","LU2272731782.SGD","WDNA","MRNX","RSPH","IEIH","LU2272731865.HKD","PPH","AZNH","IE00B4R5TH58.HKD","AMGN","IEHS","LU1992135472.HKD","IDNA","TMED","CANC","BIOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198157419","title":"福泰制药宣布Inaxaplin在特定AMKD患者群体中取得积极结果,第13周UACR显著降低42.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198157419","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198157419?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:06","pubTimestamp":1790082369,"startTime":"0","endTime":"0","summary":"路透社9月22日消息——福泰制药 今日发布重大公告,披露其在APOL1介导肾病额外患者群体中开展的2b期AMPLIFIED研究取得积极成果。详细数据显示,对于伴有中度蛋白尿的AMKD患者,Inaxaplin在治疗第13周时使尿白蛋白肌酐比较基线下降了42.7%。两项研究队列均显示,Inaxaplin总体安全性和耐受性良好,未出现意外安全信号。值得注意的是,这是福泰制药在这两个特定亚群中首次公布Inaxaplin的临床数据,进一步拓展了该药物在AMKD治疗领域的潜在应用范围。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061475181.USD","LU0256863811.USD","GNMX","TBXU","LU1585245621.USD","IE00BJT1NW94.SGD","IE00B19Z3B42.SGD","LU2468319806.SGD","IE00BZ9MQY76.HKD","LU1035775433.USD","LU2362541513.USD","LU0079474960.USD","PBE","SG9999013999.USD","SGXZ57979304.SGD","LU2089984988.USD","LU2362540622.SGD","LU1430594728.SGD","LU2417539215.USD","LU0417517546.SGD","IE0009355771.USD","IE0002270589.USD","BK4533","BK4567","BK4585","LU1093756325.SGD","LU2462157665.USD","BK4139","IE00BFTCPJ56.SGD","IBBQ","BIB","LU0320765992.SGD","IE00B19Z9P08.USD","LU0823416689.USD","BK4532","LU0289739699.SGD","LU0889565916.HKD","VRTX","LU0234570918.USD","LU1674673428.USD","LU1778281490.HKD","SG9999001176.USD","IDNA","IE00BJJMRZ35.SGD","LU1069344957.HKD","LU2456880835.USD","IBB","LU0058720904.USD","LU2236285917.USD","BK4588","LU2362541273.HKD","LU0432979614.USD","LU1093756168.USD","LU2324357040.USD","SG9999001176.SGD","BBH","IE0002141913.USD","LU2237438978.USD","IE00B2B36J28.USD","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD","LU1674673691.USD","IE00B894F039.SGD","IE00B19Z3581.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167058424","title":"安进宣布Dazodalibep治疗中重度系统性干燥综合征的3期临床试验取得积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1167058424","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167058424?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:04","pubTimestamp":1790082253,"startTime":"0","endTime":"0","summary":"安进公司今日发布重磅消息:其研发的Dazodalibep在针对中重度系统性干燥综合征的3期临床试验中,交出了一份令人振奋的答卷。这项研究聚焦于那些饱受病痛折磨的患者群体,而试验数据无疑为这片治疗荒漠带来了希望的甘霖。结果显示,与安慰剂组相比,接受Dazodalibep治疗的患者在关键疗效指标上均实现了统计学意义上的显著改善。分析人士指出,该药物的成功若能在后续环节得以延续,其市场潜力不容小觑,或将重新定义干燥综合征的治疗格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK4585","LU0289739699.SGD","BK4599","IE0002141913.USD","LU0109394709.USD","PJP","IE00B2B36J28.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0122379950.USD","BK4534","LU1983299246.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","BBH","BK4588","LU2112291526.USD","BK4566","LU1061106388.HKD","LU2242646821.SGD","BK4581","BIB","IE0009355771.USD","LU1057294990.SGD","LU0868494617.USD","PBE","TBXU","IBBQ","SG9999001440.SGD","LU0058720904.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","BK4139","AMGN","BK4533","IBB","LU2089984988.USD","LU2242652126.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196869155","title":"安进:Dazodalibep在系统性疾病活动方面展现出统计学显著且具有临床意义的改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1196869155","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196869155?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:01","pubTimestamp":1790082073,"startTime":"0","endTime":"0","summary":"安进公司宣布,其实验性药物Dazodalibep在治疗中取得了重大突破。最新研究数据显示,该药物在改善系统性疾病活动方面,不仅达到了统计学上的显著效果,更在临床实践中展现出切实的改善意义。\n这一积极结果无疑为患者群体带来了新的希望,同时也为安进在竞争激烈的医药研发领域增添了重要砝码。相关研究的具体数据与详细分析,预计将在后续的医学会议或学术期刊中进一步披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE0009355771.USD","LU2468319806.SGD","IBBQ","BK4585","LU0122379950.USD","IE00B2B36J28.USD","BK4588","BK4533","BK4139","LU2089984988.USD","BK4534","LU1057294990.SGD","IE00BJJMRZ35.SGD","BK4581","TBXU","BIB","LU0320765992.SGD","LU0058720904.USD","LU0889565916.HKD","BBH","IBB","LU1023059063.AUD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU1571399168.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","LU2242646821.SGD","LU0109394709.USD","LU0289739699.SGD","LU0868494617.USD","LU1983299246.USD","LU2242652126.USD","PJP","BK4599","SG9999001440.SGD","IE00BJT1NW94.SGD","AMGN","LU2112291526.USD","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144298886","title":"安进:Dazodalibep治疗中重度症状性干燥综合征的Oasiz 303三期研究预计2026年第四季度完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1144298886","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144298886?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:00","pubTimestamp":1790082009,"startTime":"0","endTime":"0","summary":"安进(Amgen)披露,其针对中重度症状性干燥综合征(Sjögren's Disease)所开展的Dazodalibep三期临床研究——即Oasiz 303试验,预计将于2026年第四季度圆满完成。这一时间表的明确,为该公司在自身免疫疾病领域的管线推进提供了新的节点参照。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU1023059063.AUD","PBE","LU2242652126.USD","LU1571399168.USD","IE0009355771.USD","LU1983299246.USD","LU0889565916.HKD","LU2468319806.SGD","PJP","LU0320765992.SGD","BK4139","BK4581","IE00BFTCPJ56.SGD","LU0058720904.USD","BBH","LU0289739699.SGD","LU2112291526.USD","AMGN","SG9999001440.SGD","LU1057294990.SGD","LU2242646821.SGD","BK4534","TBXU","BK4566","IE0002141913.USD","LU0868494617.USD","IE00BJJMRZ35.SGD","BK4588","IE00BJT1NW94.SGD","BK4599","LU0109394709.USD","BK4585","LU1061106388.HKD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU2089984988.USD","BK4533","BIB","LU0122379950.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196050236","title":"福泰制药:Inaxaplin在两种AMKD患者队列中均展现良好安全性与耐受性","url":"https://stock-news.laohu8.com/highlight/detail?id=1196050236","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196050236?lang=zh_cn&edition=full","pubTime":"2026-09-22 20:02","pubTimestamp":1790078535,"startTime":"0","endTime":"0","summary":"福泰制药近日披露,其候选药物Inaxaplin在两项针对APOL1介导肾病的临床试验队列中,表现出令人满意的安全性和耐受性特征。业内观察人士指出,Inaxaplin若能在后续研究中持续印证其价值,有望为AMKD这一难治性疾病带来突破性治疗选择。福泰制药此番公告,不仅回应了市场对管线进展的关切,也再次凸显了其在精准医疗赛道上的深耕意图。随着更多数据的积累,Inaxaplin的临床定位将愈发清晰,其对患者生活质量的实际改善程度也将接受更严苛的检验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","LU2362540622.SGD","IBB","BK4533","PBE","LU1674673691.USD","IE00BFTCPJ56.SGD","LU0234570918.USD","LU0823416689.USD","LU0289739699.SGD","LU1585245621.USD","LU2237438978.USD","VRTX","LU2468319806.SGD","BK4532","BK4567","LU1674673428.USD","LU2362541513.USD","GNMX","LU1093756168.USD","LU2089984988.USD","LU0432979614.USD","LU1035775433.USD","IE00B19Z3581.USD","IE0002270589.USD","LU2456880835.USD","LU0109394709.USD","LU1778281490.HKD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU2236285917.USD","LU0256863811.USD","BK4585","IE0002141913.USD","BK4139","IE00B4R5TH58.HKD","IE0009355771.USD","LU0320765992.SGD","LU2324357040.USD","IDNA","IE00B894F039.SGD","LU0058720904.USD","LU0417517546.SGD","SGXZ57979304.SGD","LU2362541273.HKD","LU0889565916.HKD","LU1069344957.HKD","BIB","IE00BJT1NW94.SGD","LU1430594728.SGD","BBH","BK4588","IE00B19Z3B42.SGD","SG9999001176.USD","IE00B19Z9P08.USD","SG9999001176.SGD","LU2462157665.USD","LU0061475181.USD","TBXU","SG9999013999.USD","LU1093756325.SGD","IBBQ","LU2417539215.USD","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160767959","title":"福泰制药公布Inaxaplin针对APOL1介导肾病(AMKD)其他人群的2B期AMPLIFIED研究积极结果,并完成2/3期AMPLITUDE试验入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1160767959","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160767959?lang=zh_cn&edition=full","pubTime":"2026-09-22 20:01","pubTimestamp":1790078494,"startTime":"0","endTime":"0","summary":"福泰制药今日宣布,其候选药物Inaxaplin在针对APOL1介导肾病其他患者群体的2B期AMPLIFIED研究中,取得了令人鼓舞的积极数据。与此同时,公司还确认,备受瞩目的2/3期AMPLITUDE注册试验已顺利达成全部患者入组目标。目前,该疾病在全球范围内缺乏针对性治疗手段,Inaxaplin有望为患者带来突破性的治疗选择。业内分析人士认为,AMPLIFIED研究的积极结果以及AMPLITUDE试验的顺利入组,进一步巩固了福泰制药在肾脏病精准医疗领域的领先地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU2324357040.USD","LU0061475181.USD","LU2417539215.USD","LU0058720904.USD","VRTX","BBH","LU2462157665.USD","LU0432979614.USD","LU1585245621.USD","LU2362541273.HKD","IE00B894F039.SGD","LU1093756168.USD","IE00BFTCPJ56.SGD","BK4588","LU1035775433.USD","IE0002141913.USD","IE00B19Z9P08.USD","IE00B2B36J28.USD","LU1093756325.SGD","SGXZ57979304.SGD","IE00B19Z9Z06.USD","LU1778281490.HKD","LU1674673428.USD","IE00BZ9MQY76.HKD","IE00B19Z3581.USD","LU0823416689.USD","LU2236285917.USD","LU2468319806.SGD","SG9999013999.USD","LU0109394709.USD","IE0002270589.USD","IE00B19Z3B42.SGD","IE00B4R5TH58.HKD","LU1674673691.USD","BK4533","LU0256863811.USD","LU2456880835.USD","IBB","LU0079474960.USD","LU1430594728.SGD","BK4567","LU2237438978.USD","BK4585","TBXU","BK4532","IE00BJT1NW94.SGD","IBBQ","IDNA","LU0417517546.SGD","LU2089984988.USD","LU0234570918.USD","LU1069344957.HKD","LU0889565916.HKD","SG9999001176.USD","IE00BJJMRZ35.SGD","SG9999001176.SGD","PBE","LU2362541513.USD","LU0320765992.SGD","BK4139","GNMX","LU2362540622.SGD","LU0289739699.SGD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191181268","title":"福泰制药:Inaxaplin显著降低UACR达42.7%——针对适度蛋白尿APKD患者展现积极疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1191181268","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191181268?lang=zh_cn&edition=full","pubTime":"2026-09-22 20:01","pubTimestamp":1790078474,"startTime":"0","endTime":"0","summary":"生物制药巨头福泰制药近日披露了一项令人瞩目的临床数据:其候选药物Inaxaplin在治疗伴有适度蛋白尿的常染色体显性多囊肾病患者中,于第13周时使尿白蛋白肌酐比较基线大幅下降42.7%。值得关注的是,这项数据凸显了Inaxaplin在降低蛋白尿方面的显著潜力,而蛋白尿正是衡量肾脏损伤程度及预测疾病进展风险的关键生物标志物。尽管现有数据展现出鼓舞人心的信号,但业界普遍认为,要全面评估Inaxaplin的长期获益与安全性,尚需更大规模、更长周期的临床验证。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541513.USD","LU2468319806.SGD","LU0823416689.USD","LU0234570918.USD","BK4585","IDNA","IE00B19Z9P08.USD","LU0256863811.USD","IBB","BIB","IE00BZ9MQY76.HKD","PBE","LU0079474960.USD","LU2324357040.USD","LU1674673428.USD","LU1069344957.HKD","LU2462157665.USD","LU0320765992.SGD","SG9999001176.USD","LU2236285917.USD","VRTX","LU0061475181.USD","IE00B4R5TH58.HKD","LU1430594728.SGD","LU2362540622.SGD","IE00B19Z3581.USD","GNMX","LU0889565916.HKD","LU0417517546.SGD","LU0432979614.USD","LU1035775433.USD","LU2089984988.USD","LU2456880835.USD","IE00B19Z3B42.SGD","IE0002141913.USD","LU2417539215.USD","IE0009355771.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1093756168.USD","IE0002270589.USD","LU0058720904.USD","LU1674673691.USD","SGXZ57979304.SGD","BK4588","LU1585245621.USD","TBXU","BBH","LU0109394709.USD","LU2362541273.HKD","LU0289739699.SGD","BK4533","IE00B19Z9Z06.USD","IE00BJJMRZ35.SGD","BK4532","LU2237438978.USD","BK4139","SG9999013999.USD","IE00BFTCPJ56.SGD","BK4567","LU1093756325.SGD","IE00B894F039.SGD","SG9999001176.SGD","LU1778281490.HKD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147475205","title":"福泰制药获Leerink Partners恢复覆盖,给予跑赢大盘评级及594美元目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1147475205","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147475205?lang=zh_cn&edition=full","pubTime":"2026-09-21 18:04","pubTimestamp":1789985058,"startTime":"0","endTime":"0","summary":"Leerink Partners近日宣布恢复对福泰制药的覆盖研究,并给予该股\"跑赢大盘\"评级。这家华尔街投行同时将目标价设定为594美元,彰显其对福泰制药未来走势的乐观预期。这一动作引发市场广泛关注——毕竟,Leerink Partners在生物医药领域的分析素以严谨著称。其恢复覆盖并给出积极评级,无疑为投资者注入了一针强心剂。值得注意的是,这一评级决定恰逢生物科技板块整体回暖之际。多重因素交织下,福泰制药的股价表现或将迎来新的催化剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU0256863811.USD","LU2362541513.USD","IE00BJT1NW94.SGD","LU1035775433.USD","IBBQ","IE0002141913.USD","GNMX","LU1674673691.USD","PBE","LU0109394709.USD","IE00B19Z3581.USD","IE00B894F039.SGD","LU1093756325.SGD","LU2417539215.USD","IE00B19Z9P08.USD","LU1585245621.USD","BIB","LU0234570918.USD","BBH","LU2362541273.HKD","LU2089984988.USD","IBB","LU0079474960.USD","IE00BFTCPJ56.SGD","IE00BZ9MQY76.HKD","LU2456880835.USD","IE0002270589.USD","IE00B2B36J28.USD","LU1093756168.USD","LU1069344957.HKD","BK4588","LU2236285917.USD","LU0320765992.SGD","LU0417517546.SGD","IE00B19Z3B42.SGD","LU2468319806.SGD","IE0009355771.USD","IE00B19Z9Z06.USD","LU1674673428.USD","VRTX","LU0432979614.USD","LU0289739699.SGD","LU2324357040.USD","LU1430594728.SGD","BK4532","IE00B4R5TH58.HKD","LU2362540622.SGD","BK4533","BK4585","BK4567","SG9999001176.SGD","LU1778281490.HKD","SG9999001176.USD","SGXZ57979304.SGD","LU2462157665.USD","LU2237438978.USD","LU0061475181.USD","LU0823416689.USD","LU0889565916.HKD","BK4139","TBXU","SG9999013999.USD","IDNA","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164691459","title":"吉利德科学扩大六项免许可费自愿授权协议,力推每年一次HIV预防药Lenacapavir","url":"https://stock-news.laohu8.com/highlight/detail?id=1164691459","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164691459?lang=zh_cn&edition=full","pubTime":"2026-09-16 20:31","pubTimestamp":1789561872,"startTime":"0","endTime":"0","summary":"吉利德科学宣布,扩大其六项免许可费的自愿授权协议,覆盖其每年仅需注射一次的HIV预防药物Lenacapavir。此举旨在拓宽药物可及性,助力全球抗击艾滋病疫情。通过这一系列协议,吉利德希望加快该长效预防方案在中低收入国家的推广,以应对持续存在的公共卫生挑战。该举措不仅彰显了公司在全球健康公平方面的承诺,也为实现2030年终结艾滋病流行的目标注入新动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948541.HKD","LU2357627491.SGD","LU0965509101.SGD","SG9999015945.SGD","LU2087621335.USD","TBXU","LU1585245621.USD","LU0965508806.USD","GILD","IE00B19Z3B42.SGD","LU0965509010.AUD","LU2468319806.SGD","SG9999015986.USD","BK4550","BK4583","LU1057294990.SGD","LU2089984988.USD","LU1430594728.SGD","LU1061106388.HKD","SG9999015952.SGD","IE00BSNM7G36.USD","LU1934455277.USD","TMED","LU1066053197.SGD","LU1571399168.USD","BMED","IE0002270589.USD","BK4568","BK4585","IE00B7SZLL34.SGD","LU0114720955.EUR","LU0859254822.USD","BK4139","LU0882574055.USD","IBBQ","LU1934455194.USD","BIB","LU0320765992.SGD","LU0823416689.USD","BK4532","BK4578","LU2112291526.USD","LU0289739699.SGD","LU1934455863.HKD","SG9999015978.USD","LU0889565916.HKD","LU0234570918.USD","LU1674673428.USD","LU0122379950.USD","LU1778281490.HKD","LU0861579265.USD","IE00B3T34201.USD","LU1023059063.AUD","IBB","LU0058720904.USD","BK4588","IE00BZ1G4Q59.USD","LU1066051498.USD","LU2324357040.USD","LU1037948897.HKD","MEDI","BBH","BK4566","LU1674673691.USD","IE00BKVL7J92.USD","LU0965509283.SGD","IE00B19Z3581.USD","LU1839511570.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667267605","title":"百时美施贵宝就安进拟推出的Opdivo生物类似药提起诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2667267605","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667267605?lang=zh_cn&edition=full","pubTime":"2026-09-16 10:15","pubTimestamp":1789524901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0868494617.USD","LU0225284248.USD","BK4588","LU1670711123.USD","BK4139","IE00BSNM7G36.USD","IE00B4R5TH58.HKD","PJP","PPH","LU0109394709.USD","LU1236620834.HKD","BIB","BK4559","LU1868837300.USD","LU1868836757.USD","BK4585","LU1989771016.USD","LU2322448957.HKD","LU2473716301.USD","LU1992135399.USD","TBXU","BK4566","LU0320765992.SGD","BK4533","IE0009355771.USD","LU2272731600.USD","BMY","LU2125154778.USD","FTXH","LU2272731865.HKD","AMGN","IBB","LU2468319806.SGD","LU1983299246.USD","BBH","LU0061475181.USD","BK4534","LU1883839398.USD","LU0289739699.SGD","LU0225771236.USD","IHE","LU1023059063.AUD","LU1236620750.USD","LU1261432733.SGD","LU0058720904.USD","PBE","IBBQ","LU1868836591.USD","XPH","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120765496","title":"吉利德科学携手巴西卫生部,共促Lenacapavir本地化生产新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=1120765496","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120765496?lang=zh_cn&edition=full","pubTime":"2026-09-15 23:15","pubTimestamp":1789485331,"startTime":"0","endTime":"0","summary":"吉利德科学公司近日透露,正积极与巴西卫生部探索合作良机,旨在助力该国实现Lenacapavir药物的本土生产愿景。这一举措,无疑为巴西医药产业自主化进程注入了强劲动力。据悉,双方的洽谈聚焦于如何深化协作,以切实推进巴西卫生部既定的战略目标——即构建并强化Lenacapavir的本地制造能力。Lenacapavir,作为一款备受瞩目的长效抗逆转录病毒药物,其本地化生产若能落地,对巴西乃至更广泛地区的HIV防治工作意义深远。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1066053197.SGD","BK4566","BK4578","IE00BZ1G4Q59.USD","LU2112291526.USD","LU1778281490.HKD","LU1934455194.USD","LU2468319806.SGD","IBB","IE00BSNM7G36.USD","LU0109394709.USD","LU1037948541.HKD","LU0234570918.USD","LU1037948897.HKD","BK4583","LU0882574055.USD","GILD","IE00BKVL7J92.USD","BK4532","LU0889565916.HKD","LU0320765992.SGD","LU0861579265.USD","LU1061106388.HKD","LU1430594728.SGD","LU1571399168.USD","LU2089984988.USD","IE00B19Z3581.USD","BK4585","LU0965509283.SGD","SG9999015986.USD","LU1934455277.USD","TBXU","BK4568","IBBQ","LU0859254822.USD","LU1023059063.AUD","LU0122379950.USD","LU0114720955.EUR","BMED","SG9999015978.USD","LU2324357040.USD","TMED","LU1585245621.USD","LU2357627491.SGD","LU0965509010.AUD","SG9999015952.SGD","BK4550","LU1674673428.USD","LU0965508806.USD","IE00B19Z3B42.SGD","LU0823416689.USD","LU0289739699.SGD","IE00B7SZLL34.SGD","IE00B3T34201.USD","BBH","SG9999015945.SGD","LU1057294990.SGD","LU1839511570.USD","LU1066051498.USD","LU1674673691.USD","BK4139","BIB","MEDI","IE0002270589.USD","LU0058720904.USD","LU0965509101.SGD","LU1934455863.HKD","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vaneck.com/etf/equity/bbh/overview/","stockEarnings":[{"period":"1week","weight":-0.038},{"period":"1month","weight":-0.02},{"period":"3month","weight":0.1291},{"period":"6month","weight":0.2465},{"period":"1year","weight":0.3573},{"period":"ytd","weight":0.2485}],"compareEarnings":[{"period":"1week","weight":0.0195},{"period":"1month","weight":0.0116},{"period":"3month","weight":0.0452},{"period":"6month","weight":0.1459},{"period":"1year","weight":0.16},{"period":"ytd","weight":0.1425}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.034474},{"month":2,"riseRate":0.533333,"avgChangeRate":-0.001737},{"month":3,"riseRate":0.466667,"avgChangeRate":-0.001534},{"month":4,"riseRate":0.4,"avgChangeRate":0.001235},{"month":5,"riseRate":0.6,"avgChangeRate":0.01217},{"month":6,"riseRate":0.8,"avgChangeRate":0.026892},{"month":7,"riseRate":0.933333,"avgChangeRate":0.049139},{"month":8,"riseRate":0.6,"avgChangeRate":0.01477},{"month":9,"riseRate":0.466667,"avgChangeRate":-0.008414},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.007539},{"month":11,"riseRate":0.785714,"avgChangeRate":0.046381},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.017373}],"exchange":"NASDAQ","name":"VanEck Biotech ETF","nameEN":"VanEck Biotech ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VanEck Biotech ETF(BBH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供VanEck Biotech ETF(BBH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"VanEck Biotech ETF,BBH,VanEck Biotech ETF股票,VanEck Biotech ETF股票老虎,VanEck Biotech ETF股票老虎国际,VanEck Biotech ETF行情,VanEck Biotech ETF股票行情,VanEck Biotech ETF股价,VanEck Biotech ETF股市,VanEck Biotech ETF股票价格,VanEck Biotech ETF股票交易,VanEck Biotech ETF股票购买,VanEck Biotech ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VanEck Biotech ETF(BBH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供VanEck Biotech ETF(BBH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}